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The different subfamilies of  defensins are thought to share a common ancestry. Human α- 
and β-defensins gene family is in the main locus on chromosome 8p22-23. 
The tertiary structures of human β-defensins are very similar despite low sequence 
conservation in their amino acids. Their cationic structure is composed by 3 β-strands 
arranged in an antiparallel sheet stabilized by 3 intramolecular disulfide bonds between 6 
cysteine and flanked by an α-helix. 
 
 
 
 
 
 
Figure 1. β-defensins sequences and properties. Cysteine residues highlighted in red, basic 
residues in blue and conserved glycine in green. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The attachment of peptides is initiated by electrostatic interactions with the 
negatively charged membranes of pathogens. The hydrophobic residues enable their 
internalization and pore formation until pathogen is killed by osmotic shock. 
High salt concentrations inhibit the attachment of β-defensins except HBD3. 
STRUCTURE ANTIMICROBIAL  ACTIVITY 
Defensins are small cationic antimicrobial peptides involved in innate immunity and highly conserved in vertebrates. In humans, defensins are classified into two subgroups (α and β) based on both 
unique amino acid sequences and disulfide bonds. α-defensines are mostly expressed by neutrophils and β-defensins are secreted by epithelial cells of the skin and mucosae. Despite their 
antimicrobial activity against bacteria, viruses, fungi and protozoa, they are modulators of the adaptive immunity. The most studied human β-defensins are HBD1, HBD2 and HBD3 but the predicted 
peptide sequence is available for all human β-defensins known. 
INTRODUCTION 
Despite HBD4 has not been isolated in vivo, this peptide exhibits the strongest antimicrobial activity but only at low ionic strength. Moreover, HBD3 has a broad spectrum activity but weaker than 
HBD4 and it is not inhibit at high salt concentrations. My aim is to modify the HBD4 amino acid sequence mimicking the HBD3 sequence to introduce its features in a synthetic HBD4. 
AIMS 
β-defensins are a rapidly evolving peptide family with low sequence similarity between 
paralogs. However, some  gene regions evolve under positive selection and they are 
directly involved in mature peptide function. 
According to my aim, I have changed some HBD4 residues subject to positive selection 
mimicking the HBD3 homologues sites and increasing the net charge of own peptide. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Sites subject to positive selection are mapped to the structure of HBD1 mature 
peptide. Sites subject to selection are colored red and the particular residues are named 
and arrowed. 
 
Figure 4 (right site). Native HBD4 followed by designed peptides named with a roman 
number (I-XX), modified residues are highlighted in yellow. 
DESIGN OF PEPTIDES 
PEPTIDES SEQUENCES NET CHARGE 
HBD4 ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRK +7 
HBD4-I ELDRICRYGTARCRKKCRSQEYRIGRCPNTYACCLRK +8 
HBD4-II ELDRICRYRTARCRKKCRSQEYRIGRCPNTYACCLRK +9 
HBD4-III ELDRICRVRTARCRKKCRSQEYRIGRCPNTYACCLRK +9 
HBD4-IV ELDRYCRYRTARCRKKCRSQEYRIGRCPNTYACCLRK +9 
HBD4-V ELDRICGYGTARCRKSCRSQEYRIGRCPNTYACCLRK +6 
HBD4-VI ELDRICGYGTARCRKKCRSQEYRIGRCPRTYACCLRK +8 
HBD4-VII ELDRICGYGTARCRKKCRSQEYRIGRCPNTRACCLRK +8 
HBD4-VIII ELDRICGYGTARCRKKCRSQEYRIGRCPRTRACCLRK +9 
HBD4-IX ELDRICGYGTARCRKKCRSQEYRIGRCPNTRRCCLRK +9 
HBD4-X ELDRICGYGTARCRKKCRSQEYRIGRCPRTRRCCLRK +10 
HBD4-XI ELDRICGYGTARCRKKCRSQEYRIGRCPRTRRCCRRK +11 
HBD4-XII ELDRICRYGTARCRKKCRSQEYRIGRCPNTYRCCLRK +9 
HBD4-XIII ELDRICRYRTARCRKKCRSQEYRIGRCPNTYRCCLRK +10 
HBD4-XIV ELDRICRYRTARCRKKCRSQEYRIGRCPNTRRCCLRK +11 
HBD4-XV ELDRICRYRTARCRKKCRSQEYRIGRCPRTRRCCLRK +12 
HBD4-XVI ELDRICRYRTARCRKKCRSQEYRIGRCPRTRRCCRRK +13 
HBD4-XVII ELDRYCRYGTARCRKKCRSQEYRIGRCPNTRRCCLRK +10 
HBD4-XVIII ELDRYCRYRTARCRKKCRSQEYRIGRCPNTRRCCLRK +11 
HBD4-XIX ELDRYCRYRTARCRKKCRSQEYRIGRCPRTRRCCLRK +12 
HBD4-XX ELDRYCRYRTARCRKKCRSQEYRIGRCPRTRRCCRRK +13 
If the results of antimicrobial assay are good, we can expect  an improvement of own peptides functions. The first four peptides possess a α-helix-like HBD3 which is responsible of the attachment to 
pathogens membrane, therefore we could expect a wider spectrum activity. The second group of peptides have a higher number of basic residues which increase the net charge and allegedly their 
antimicrobial activity and salt concentrations resistance. This assumption is supported by the fact that HBD3 possess the highest net charge value and it is not inhibit at high salt concentrations. 
Finally, the last group of peptides have been designed to incorporate the previous features into one peptide. 
 
The analysis of the structural and functional characteristics of β-defensins opens the way to the engineering of these peptides with therapeutic applications. This study could show that the rational 
design of these hybrid peptides is possible. 
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